A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY EVALUATING PERIOPERATIVE TORIPALIMAB COMBINED WITH PLATINUM-BASED DOUBLET CHEMOTHERAPY IN RESECTABLE STAGE III NSCLC
Wang, Wenxiang2; Wu, Lin2; Zhang, Wei3; Lu, Shun4; Fang, Haohui5; Yu, Guohua6; Zhou, Ming7; Xing, Wenqun8; Chen, Qixun9; Li, Xingya10
刊名JOURNAL FOR IMMUNOTHERAPY OF CANCER
2020-11-01
卷号8
DOI10.1136/jitc-2020-SITC2020.0366
WOS研究方向Oncology ; Immunology
语种英语
出版者BMJ PUBLISHING GROUP
WOS记录号WOS:000616665300355
内容类型期刊论文
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/119581]  
专题中国科学院合肥物质科学研究院
作者单位1.Xiamen Univ, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China
2.Hunan Canc Hosp, Changsha, Hunan, Peoples R China
3.Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
4.Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China
5.Anhui Chest Hosp, Hefei, Anhui, Peoples R China
6.Weifang Peoples Hosp, Weifang, Peoples R China
7.Guangzhou Med Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China
8.Henan Canc Hosp, Zhengzhou, Henan, Peoples R China
9.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Zhejiang, Peoples R China
10.Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
推荐引用方式
GB/T 7714
Wang, Wenxiang,Wu, Lin,Zhang, Wei,et al. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY EVALUATING PERIOPERATIVE TORIPALIMAB COMBINED WITH PLATINUM-BASED DOUBLET CHEMOTHERAPY IN RESECTABLE STAGE III NSCLC[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER,2020,8.
APA Wang, Wenxiang.,Wu, Lin.,Zhang, Wei.,Lu, Shun.,Fang, Haohui.,...&Xu, Tao.(2020).A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY EVALUATING PERIOPERATIVE TORIPALIMAB COMBINED WITH PLATINUM-BASED DOUBLET CHEMOTHERAPY IN RESECTABLE STAGE III NSCLC.JOURNAL FOR IMMUNOTHERAPY OF CANCER,8.
MLA Wang, Wenxiang,et al."A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY EVALUATING PERIOPERATIVE TORIPALIMAB COMBINED WITH PLATINUM-BASED DOUBLET CHEMOTHERAPY IN RESECTABLE STAGE III NSCLC".JOURNAL FOR IMMUNOTHERAPY OF CANCER 8(2020).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace